BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27798936)

  • 1. Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients.
    Bakanidze G; Brandl EJ; Hutzler C; Aurass F; Onken S; Rapp MA; Puls I
    Neuropsychobiology; 2016; 74(1):41-47. PubMed ID: 27798936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.
    Varela-Gomez N; Mata I; Perez-Iglesias R; Rodriguez-Sanchez JM; Ayesa R; Fatjo-Vilas M; Crespo-Facorro B
    Cogn Neuropsychiatry; 2015; 20(2):144-56. PubMed ID: 25530342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.
    Correa DD; Satagopan J; Cheung K; Arora AK; Kryza-Lacombe M; Xu Y; Karimi S; Lyo J; DeAngelis LM; Orlow I
    Neuro Oncol; 2016 Oct; 18(10):1425-33. PubMed ID: 27091610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic variations in DTNBP1 with cognitive function in schizophrenia patients and healthy subjects.
    Baek JH; Kim JS; Ryu S; Oh S; Noh J; Lee WK; Park T; Lee YS; Lee D; Kwon JS; Hong KS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):841-9. PubMed ID: 22911901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia.
    Cheah SY; Lawford BR; Young RM; Morris CP; Voisey J
    Eur Psychiatry; 2015 Jun; 30(4):486-91. PubMed ID: 25697573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects.
    Hashimoto R; Noguchi H; Hori H; Ohi K; Yasuda Y; Takeda M; Kunugi H
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):550-6. PubMed ID: 19496996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the human dystrobrevin-binding protein 1 gene in schizophrenic patients.
    Liao HM; Chen CH
    Schizophr Res; 2004 Nov; 71(1):185-9. PubMed ID: 15374586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the DTNBP1 genotype with cognition and personality traits in healthy subjects.
    Kircher T; Markov V; Krug A; Eggermann T; Zerres K; Nöthen MM; Skowronek MH; Rietschel M
    Psychol Med; 2009 Oct; 39(10):1657-65. PubMed ID: 19335929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level.
    Stefanis NC; Trikalinos TA; Avramopoulos D; Smyrnis N; Evdokimidis I; Ntzani EE; Ioannidis JP; Stefanis CN
    Biol Psychiatry; 2007 Oct; 62(7):784-92. PubMed ID: 17336946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.
    Voisey J; Swagell CD; Hughes IP; Lawford BR; Young RM; Morris CP
    Eur Psychiatry; 2010 Oct; 25(6):314-9. PubMed ID: 20615671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DTNBP1 genotype influences cognitive decline in schizophrenia.
    Burdick KE; Goldberg TE; Funke B; Bates JA; Lencz T; Kucherlapati R; Malhotra AK
    Schizophr Res; 2007 Jan; 89(1-3):169-72. PubMed ID: 17074466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.
    Hashimoto R; Noguchi H; Hori H; Nakabayashi T; Suzuki T; Iwata N; Ozaki N; Kosuga A; Tatsumi M; Kamijima K; Harada S; Takeda M; Saitoh O; Kunugi H
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):431-8. PubMed ID: 19353385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample.
    Prasad KM; Almasy L; Gur RC; Gur RE; Pogue-Geile M; Chowdari KV; Talkowski ME; Nimgaonkar VL
    Schizophr Bull; 2010 Sep; 36(5):983-90. PubMed ID: 19282471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis.
    Li D; He L
    Schizophr Res; 2007 Nov; 96(1-3):112-8. PubMed ID: 17604607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of candidate variants from brain-derived neurotrophic factor and dystrobrevin-binding protein 1 with neuroticism, anxiety, and depression.
    Wray NR; James MR; Handoko HY; Dumenil T; Lind PA; Montgomery GW; Martin NG
    Psychiatr Genet; 2008 Oct; 18(5):219-25. PubMed ID: 18797396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals.
    Cho Y; Ryu S; Huh I; Cho EY; Oh H; Lee YS; Lee WK; Park T; Kwon JS; Hong KS
    Psychiatr Genet; 2015 Aug; 25(4):147-54. PubMed ID: 25967537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.
    Fanous AH; van den Oord EJ; Riley BP; Aggen SH; Neale MC; O'Neill FA; Walsh D; Kendler KS
    Am J Psychiatry; 2005 Oct; 162(10):1824-32. PubMed ID: 16199828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.